{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:42:25Z","timestamp":1794368545218,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T00:00:00Z","timestamp":1651881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous studies have shown that frozen embryo transfer (FET) resulted in increased live birth rates (LBR) and reduced the risk of ovarian hyperstimulation syndrome (OHSS) than did fresh embryo transfer in women with polycystic ovary syndrome (PCOS). In addition, overweight\/obese women with PCOS are at increased risk of subfertility and complications of pregnancy, compared with normal-weight women. The ovarian stimulation and artificial hormone regimes are the two more commonly used endometrial preparation protocols in PCOS patients.This retrospective study aims to compare the pregnancy outcomes of mildly stimulated cycles (mSTC) and artificial cycles (AC) prior to FET in overweight\/obese women with PCOS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective analysis was conducted in overweight\/obese women with PCOS who underwent their first FET cycles from January 2018 to December 2020. Two endometrial preparation protocols were used: the mildly stimulated cycles (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009173) and the artificial cycles (\n                      <jats:italic>N<\/jats:italic>\n                      \u2009=\u2009507). All pregnancy outcomes were analyzed by Student\u2019s\n                      <jats:italic>t<\/jats:italic>\n                      -test, Chi-square (\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>\n                        <jats:italic>2<\/jats:italic>\n                      <\/jats:sup>\n                      ) statistics and multivariable logistic regression analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      This study enrolled 680 cases of FET cycles. The mSTC group exhibited significantly higher LBR compared with the AC group (49.7% vs. 41.0%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009\n                      <jats:italic>0.046<\/jats:italic>\n                      ), while the rate of miscarriage was significantly lower (6.4% vs. 23.0%;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u2009\n                      <jats:italic>0.001<\/jats:italic>\n                      ). No statistically significant differences were observed in positive pregnancy rate (57.8% vs. 60.0%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009\n                      <jats:italic>0.618<\/jats:italic>\n                      ), clinical pregnancy rate (54.3% vs. 55.6%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009\n                      <jats:italic>0.769<\/jats:italic>\n                      ), and ectopic pregnancy rate (2.1% vs. 3.2%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009\n                      <jats:italic>0.860<\/jats:italic>\n                      ) between two groups. After adjusting for possible confounding factors, multivariate logistic regression analysis also yielded similar results.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For overweight\/obese women with PCOS, mSTC-FET demonstrated a higher LBR and a lower pregnancy loss rate than that in the AC-FET. When considering the most cost-effective treatment with the least adverse effects on patients, the mSTC for FET endometrial preparation may be considered. To corroborate our findings, additional prospective randomized clinical trials with larger sample sizes are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-022-04728-6","type":"journal-article","created":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T10:02:22Z","timestamp":1651917742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The effect of mildly stimulated cycle versus artificial cycle on pregnancy outcomes in overweight\/obese women with PCOS prior to frozen embryo transfer: a retrospective cohort study"],"prefix":"10.1186","volume":"22","author":[{"given":"Lu","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haicui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaofeng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,7]]},"reference":[{"issue":"4","key":"4728_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1515\/jomb-2017-0068","volume":"37","author":"E Bakeer","year":"2018","unstructured":"Bakeer E, Radwan R, El Mandoury A, El Rahman AA, Gad M, El Maksoud SA. Anti-M\u00fcllerian Hormone as a Diagnostic Marker in Egyptian Infertile Polycystic Ovary Syndrome Females: Correlations with Vitamin D, Total Testosterone, Dyslipidemia and Anthropometric Parameters. J Med Biochem. 2018;37(4):448\u201355.","journal-title":"J Med Biochem"},{"issue":"19","key":"4728_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","volume":"166","author":"F Alvarez-Blasco","year":"2006","unstructured":"Alvarez-Blasco F, Botella-Carretero JI, San Mill\u00e1n JL, Escobar-Morreale HF. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women. Arch Intern Med. 2006;166(19):2081\u20136.","journal-title":"Arch Intern Med"},{"issue":"1","key":"4728_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BC Fauser","year":"2012","unstructured":"Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, Carmina E, Chang J, Yildiz BO, Laven JS, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97(1):28-38.e25.","journal-title":"Fertil Steril"},{"issue":"9","key":"4728_CR4","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","volume":"28","author":"R Li","year":"2013","unstructured":"Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, Wei Z, Song X, Wang X, Fu S, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28(9):2562\u20139.","journal-title":"Hum Reprod"},{"issue":"6","key":"4728_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","volume":"18","author":"SS Lim","year":"2012","unstructured":"Lim SS, Davies MJ, Norman RJ, Moran LJ. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618\u201337.","journal-title":"Hum Reprod Update"},{"issue":"04","key":"4728_CR6","first-page":"221","volume":"9","author":"AH Jia","year":"2017","unstructured":"Jia AH, Xu SY, Ming J, Zhou J, Guo JH, Liu C, Hao PR, Ji QH. Epidemiological characteristics of obesity under different diagnostic criteria in China. Chin J Diabetes. 2017;9(04):221\u20135.","journal-title":"Chin J Diabetes"},{"issue":"1","key":"4728_CR7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0412.2000.079001043.x","volume":"79","author":"P Fedorcs\u00e1k","year":"2000","unstructured":"Fedorcs\u00e1k P, Storeng R, Dale PO, Tanbo T, Abyholm T. Obesity is a risk factor for early pregnancy loss after IVF or ICSI. Acta Obstet Gynecol Scand. 2000;79(1):43\u20138 PMID: 10646815.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"4728_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0020-7292(03)00003-1","volume":"81","author":"NO Turhan","year":"2003","unstructured":"Turhan NO, Se\u00e7kin NC, Aybar F, Ineg\u00f6l I. Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients. Int J Gynaecol Obstet. 2003;81(2):163\u20138.","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"4728_CR9","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22(6):687\u2013708.","journal-title":"Hum Reprod Update"},{"issue":"13","key":"4728_CR10","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.3109\/14767058.2015.1081167","volume":"29","author":"YM Wei","year":"2016","unstructured":"Wei YM, Yang HX, Zhu WW, Liu XY, Meng WY, Wang YQ, Shang LX, Cai ZY, Ji LP, Wang YF, et al. Risk of adverse pregnancy outcomes stratified for pre-pregnancy body mass index. J Matern Fetal Neonatal Med. 2016;29(13):2205\u20139.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"4728_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.repbio.2017.12.004","volume":"18","author":"J Zech","year":"2018","unstructured":"Zech J, Brandao A, Zech M, Lugger K, Neururer S, Ulmer H, Ruttmann-Ulmer E. Elective frozen-thawed embryo transfer (FET) in women at risk for ovarian hyperstimulation syndrome. Reprod Biol. 2018;18(1):46\u201352.","journal-title":"Reprod Biol"},{"issue":"5","key":"4728_CR12","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.fertnstert.2015.01.045","volume":"103","author":"M Roque","year":"2015","unstructured":"Roque M, Valle M, Guimar\u00e3es F, Sampaio M, Geber S. Freeze-all policy: fresh vs. frozen-thawed embryo transfer. Fertil Steril. 2015;103(5):1190\u20133.","journal-title":"Fertil Steril"},{"issue":"1","key":"4728_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fertnstert.2014.05.024","volume":"102","author":"KT Barnhart","year":"2014","unstructured":"Barnhart KT. Introduction: are we ready to eliminate the transfer of fresh embryos in in vitro fertilization? Fertil Steril. 2014;102(1):1\u20132.","journal-title":"Fertil Steril"},{"issue":"2","key":"4728_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.05.050","volume":"96","author":"BS Shapiro","year":"2011","unstructured":"Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril. 2011;96(2):344\u20138.","journal-title":"Fertil Steril"},{"issue":"11","key":"4728_CR15","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1093\/humrep\/dex285","volume":"32","author":"S Mackens","year":"2017","unstructured":"Mackens S, Santos-Ribeiro S, van de Vijver A, Racca A, Van Landuyt L, Tournaye H, Blockeel C. Frozen embryo transfer: a review on the optimal endometrial preparation and timing. Hum Reprod. 2017;32(11):2234\u201342.","journal-title":"Hum Reprod"},{"issue":"12","key":"4728_CR16","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1093\/humrep\/dew263","volume":"31","author":"M Montagut","year":"2016","unstructured":"Montagut M, Santos-Ribeiro S, De Vos M, Polyzos N, Drakopoulos P, Mackens S, van de Vijver A, van Landuyt L, Verheyen G, Tournaye H, et al. Frozen-thawed embryo transfers in natural cycles with spontaneous or induced ovulation: the search for the best protocol continues. Hum Reprod. 2016;31(12):2803\u201310.","journal-title":"Hum Reprod"},{"issue":"1","key":"4728_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12958-018-0352-z","volume":"16","author":"R Chen","year":"2018","unstructured":"Chen R, Chen S, Liu M, He H, Xu H, Liu H, Du H, Wang W, Xia X, Liu J. Pregnancy outcomes of PCOS overweight\/obese patients after controlled ovarian stimulation with the GnRH antagonist protocol and frozen embryo transfer. Reprod Biol Endocrinol. 2018;16(1):36.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"4728_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19\u201325.","journal-title":"Fertil Steril"},{"issue":"5","key":"4728_CR19","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/BF01133388","volume":"3","author":"JM Cummins","year":"1986","unstructured":"Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennessey JF. A formula for scoring human embryo growth rates in in vitro fertilization: its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J In Vitro Fert Embryo Transf. 1986;3(5):284\u201395.","journal-title":"J In Vitro Fert Embryo Transf"},{"issue":"6","key":"4728_CR20","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","volume":"73","author":"D Gardner","year":"2000","unstructured":"Gardner D, Lane M, Stevens J, Schlenker T, Schoolcraft W. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155\u20138.","journal-title":"Fertil Steril"},{"issue":"38","key":"4728_CR21","doi-asserted-by":"publisher","first-page":"e17329","DOI":"10.1097\/MD.0000000000017329","volume":"98","author":"J Song","year":"2019","unstructured":"Song J, Xiang S, Sun Z. Frozen embryo transfer at the cleavage stage can be performed within the first menstrual cycle following the freeze-all strategy without adversely affecting the live birth rate: a STROBE-compliant retrospective study. Medicine. 2019;98(38):e17329.","journal-title":"Medicine"},{"issue":"1","key":"4728_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1186\/s12884-019-2611-1","volume":"19","author":"J Lin","year":"2019","unstructured":"Lin J, Huang J, Wang N, Kuang Y, Cai R. Effects of pre-pregnancy body mass index on pregnancy and perinatal outcomes in women with PCOS undergoing frozen embryo transfer. BMC Pregnancy Childbirth. 2019;19(1):487.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"04","key":"4728_CR23","first-page":"343","volume":"38","author":"L Mu","year":"2018","unstructured":"Mu L, Zhao Y, Qiao J. Relationship between obesity and polycystic ovary syndrome and its potential mechanisms. Chin J Reprod Contracep. 2018;38(04):343\u20139.","journal-title":"Chin J Reprod Contracep"},{"issue":"2","key":"4728_CR24","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2019.04.014","volume":"112","author":"J Zhang","year":"2019","unstructured":"Zhang J, Liu H, Wang Y, Mao X, Chen Q, Fan Y, Xiao Y, Kuang Y. Letrozole use during frozen embryo transfer cycles in women with polycystic ovary syndrome. Fertil Steril. 2019;112(2):371\u20137.","journal-title":"Fertil Steril"},{"issue":"6","key":"4728_CR25","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1093\/humrep\/dex066","volume":"32","author":"T Tatsumi","year":"2017","unstructured":"Tatsumi T, Jwa SC, Kuwahara A, Irahara M, Kubota T, Saito H. Pregnancy and neonatal outcomes following letrozole use in frozen-thawed single embryo transfer cycles. Hum Reprod. 2017;32(6):1244\u20138.","journal-title":"Hum Reprod"},{"issue":"4","key":"4728_CR26","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/jcm10040703","volume":"10","author":"N Aslih","year":"2021","unstructured":"Aslih N, Dorzia D, Atzmon Y, Estrada D, Ellenbogen A, Bilgory A, Shalom-Paz E. Ovulatory-based FET cycles may achieve higher pregnancy rates in the general population and among anovulatory women. J Clin Med. 2021;10(4):703.","journal-title":"J Clin Med"},{"issue":"6","key":"4728_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/aogs.14058","volume":"100","author":"Y Man","year":"2021","unstructured":"Man Y, Bian Y, Zhao S, Zhao R, Xu X, Wei D, Li L, Chen ZJ, Zhao H. The effect of different endometrial preparations on women with polycystic ovary syndrome undergoing initial frozen embryo transfer: a historical cohort analysis. Acta Obstet Gynecol Scand. 2021;100(6):1116\u201323.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"4728_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.ejogrb.2019.10.040","volume":"243","author":"M Peign\u00e9","year":"2019","unstructured":"Peign\u00e9 M, Devouche E, Ferraretto X, Gricourt S, Luton D, Patrat C, Epelboin S. Higher live birth rate with stimulated rather than artificial cycle for frozen-thawed embryo transfer. Eur J Obstet Gynecol Reprod Biol. 2019;243:144\u20139.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"4728_CR29","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12958-020-00675-z","volume":"18","author":"A Hosseini-Najarkolaei","year":"2020","unstructured":"Hosseini-Najarkolaei A, Moini A, Kashani L, Farid Mojtahedi M, Hosseini-Najarkolaee E, Salehi E. The effect of letrozole versus artificial hormonal endometrial preparation on pregnancy outcome after frozen-thawed embryos transfer cycles: a randomized clinical trial. Reprod Biol Endocrinol. 2020;18(1):115.","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"4728_CR30","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00404-014-3396-0","volume":"291","author":"J Yu","year":"2015","unstructured":"Yu J, Ma Y, Wu Z, Li Y, Tang L, Li Y, Deng B. Endometrial preparation protocol of the frozen-thawed embryo transfer in patients with polycystic ovary syndrome. Arch Gynecol Obstet. 2015;291(1):201\u201311.","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"4728_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1080\/09513590.2020.1867976","volume":"37","author":"MF Zeng","year":"2021","unstructured":"Zeng MF, Zhou X, Duan JL. Stimulated cycle versus artificial cycle for frozen embryo transfer in patients with polycystic ovary syndrome: a meta-analysis. Gynecol Endocrinol. 2021;37(4):294\u20139.","journal-title":"Gynecol Endocrinol"},{"issue":"8","key":"4728_CR32","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1055\/a-1202-2059","volume":"80","author":"D Chen","year":"2020","unstructured":"Chen D, Shen X, Fu Y, Ding C, Zhong Y, Zhou C. Pregnancy outcomes following letrozole use in frozen-thawed embryo transfer cycles: a systematic review and meta-analysis. Geburtshilfe Frauenheilkd. 2020;80(8):820\u201333.","journal-title":"Geburtshilfe Frauenheilkd"},{"issue":"3","key":"4728_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.4103\/0974-1208.106338","volume":"5","author":"S Kar","year":"2012","unstructured":"Kar S. Clomiphene citrate or letrozole as first-line ovulation induction drug in infertile PCOS women: a prospective randomized trial. J Hum Reprod Sci. 2012;5(3):262\u20135.","journal-title":"J Hum Reprod Sci"},{"issue":"2","key":"4728_CR34","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/cen.12280","volume":"80","author":"YJ Hu","year":"2014","unstructured":"Hu YJ, Chen YZ, Zhu YM, Huang HF. Letrozole stimulation in endometrial preparation for cryopreserved-thawed embryo transfer in women with polycystic ovarian syndrome: a pilot study. Clin Endocrinol (Oxf). 2014;80(2):283\u20139.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"4728_CR35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.fertnstert.2011.07.1092","volume":"96","author":"K Wallace","year":"2011","unstructured":"Wallace K, Johnson V, Sopelak V, Hines R. Clomiphene citrate versus letrozole: molecular analysis of the endometrium in women with polycystic ovary syndrome. Fertil Steril. 2011;96(4):1051\u20136.","journal-title":"Fertil Steril"},{"issue":"2","key":"4728_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/19396368.2013.862316","volume":"60","author":"A Ganesh","year":"2014","unstructured":"Ganesh A, Chauhan N, Das S, Chakravarty B, Chaudhury K. Endometrial receptivity markers in infertile women stimulated with letrozole compared with clomiphene citrate and natural cycles. Syst Biol Reprod Med. 2014;60(2):105\u201311.","journal-title":"Syst Biol Reprod Med"},{"issue":"1","key":"4728_CR37","first-page":"125","volume":"32","author":"T Tatsumi","year":"2017","unstructured":"Tatsumi T, Jwa SC, Kuwahara A, Irahara M, Kubota T, Saito H. No increased risk of major congenital anomalies or adverse pregnancy or neonatal outcomes following letrozole use in assisted reproductive technology. Hum Reprod. 2017;32(1):125\u201332.","journal-title":"Hum Reprod"},{"issue":"6","key":"4728_CR38","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.12669\/pjms.326.11391","volume":"32","author":"Z Chen","year":"2016","unstructured":"Chen Z, Zhang M, Qiao Y, Yang J. Effects of letrozole in combination with low-dose intramuscular injection of human menopausal gonadotropin on ovulation and pregnancy of 156 patients with polycystic ovary syndrome. Pak J Med Sci. 2016;32(6):1434\u20138.","journal-title":"Pak J Med Sci"},{"issue":"6","key":"4728_CR39","first-page":"562","volume":"26","author":"F Wang","year":"2017","unstructured":"Wang F, Long HD, Deng WF, Liao HZ, Li XL, Zhang Q, Chen XM. Letrozole combined with HMG for endometrial preparation in FET cycles. J Reprod Med. 2017;26(6):562\u20137.","journal-title":"J Reprod Med"},{"issue":"3","key":"4728_CR40","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1161\/HYPERTENSIONAHA.118.12043","volume":"73","author":"F von Versen-H\u00f6ynck","year":"2019","unstructured":"von Versen-H\u00f6ynck F, Schaub AM, Chi YY, Chiu KH, Liu J, Lingis M, Stan Williams R, Rhoton-Vlasak A, Nichols WW, Fleischmann RR, et al. Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;73(3):640\u20139.","journal-title":"Hypertension"},{"issue":"3","key":"4728_CR41","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/HYPERTENSIONAHA.119.13015","volume":"74","author":"KP Conrad","year":"2019","unstructured":"Conrad KP, Petersen JW, Chi YY, Zhai X, Li M, Chiu KH, Liu J, Lingis MD, Williams RS, Rhoton-Vlasak A, et al. Maternal cardiovascular dysregulation during early pregnancy after in vitro fertilization cycles in the absence of a corpus luteum. Hypertension. 2019;74(3):705\u201315.","journal-title":"Hypertension"},{"issue":"08","key":"4728_CR42","first-page":"763","volume":"45","author":"X Li","year":"2019","unstructured":"Li X, Ling XF, Zhao C, Zhang JQ, Su Y, Zhang J. Application of different ovulation induction schemes of endometrial preparation for frozen-thawed embryo transfer cycles in patients with ovulation disorder. Jiangsu Med J. 2019;45(08):763\u20137.","journal-title":"Jiangsu Med J"},{"issue":"5","key":"4728_CR43","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.fertnstert.2018.02.135","volume":"109","author":"ER Groenewoud","year":"2018","unstructured":"Groenewoud ER, Cohlen BJ, Macklon NS. Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles. Fertil Steril. 2018;109(5):768\u201374.","journal-title":"Fertil Steril"},{"issue":"5","key":"4728_CR44","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1073\/pnas.0530162100","volume":"100","author":"WG Ma","year":"2003","unstructured":"Ma WG, Song H, Das SK, Paria BC, Dey SK. Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation. Proc Natl Acad Sci U S A. 2003;100(5):2963\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"06","key":"4728_CR45","first-page":"441","volume":"24","author":"C Jiang","year":"2015","unstructured":"Jiang C, Zhang C. Comparing the effection of endometrial preparation protocols of hormone replacement treatment with or without pituitary suppression on the outcomes of frozen thawed embryo transfer cycles. Prog Obstet Gynecol. 2015;24(06):441\u20133.","journal-title":"Prog Obstet Gynecol"},{"issue":"9","key":"4728_CR46","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10815-015-0546-7","volume":"32","author":"JD Kofinas","year":"2015","unstructured":"Kofinas JD, Blakemore J, McCulloh DH, Grifo J. Serum progesterone levels greater than 20 ng\/dl on day of embryo transfer are associated with lower live birth and higher pregnancy loss rates. J Assist Reprod Genet. 2015;32(9):1395\u20139.","journal-title":"J Assist Reprod Genet"},{"issue":"5","key":"4728_CR47","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/humrep\/dew045","volume":"31","author":"A van de Vijver","year":"2016","unstructured":"van de Vijver A, Polyzos NP, Van Landuyt L, Mackens S, Stoop D, Camus M, De Vos M, Tournaye H, Blockeel C. What is the optimal duration of progesterone administration before transferring a vitrified-warmed cleavage stage embryo? A randomized controlled trial. Hum Reprod. 2016;31(5):1097\u2013104.","journal-title":"Hum Reprod"},{"issue":"4","key":"4728_CR48","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.fertnstert.2016.01.006","volume":"105","author":"RF Casper","year":"2016","unstructured":"Casper RF, Yanushpolsky EH. Optimal endometrial preparation for frozen embryo transfer cycles: window of implantation and progesterone support. Fertil Steril. 2016;105(4):867\u201372.","journal-title":"Fertil Steril"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04728-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T00:45:56Z","timestamp":1700527556000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04728-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,7]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4728"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04728-6","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,7]]},"assertion":[{"value":"11 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board and the Institutional Ethics Committee of the Reproductive Medical Center at the affiliated Hospital of Shandong University of traditional Chinese medicine (ref approval no. SDTCM20201008). All procedures were carried out per the relevant guidelines and regulations. Furthermore, informed consent was obtained from all participants before the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that we do not have any commercial or associative interest that represents a conflict of interest in connection with the work submitted.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"394"}}